BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND FUBP1, FBP, 8880, ENSG00000162613, FUBP
17 results:

  • 1. Analysis of correlative risk factors for radiation-induced hypothyroidism in head and neck tumors.
    Wang C; Hou Y; Wang L; Yang Y; Li X
    BMC Cancer; 2024 Jan; 24(1):5. PubMed ID: 38166748
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Establishment of a predictive nomogram for differentiated thyroid cancer: an inpatient-based retrospective study.
    Du J; Li W; Zhao X; Shen C; Zhang X
    Endokrynol Pol; 2023; 74(6):. PubMed ID: 37994582
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The expression and clinical value of LRP11, fubp1 and TET1 in cervical cancer.
    Zhao X; Li S; Wen J; Li Y
    Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):80-84. PubMed ID: 37715422
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparison of ACR TI-RADS, Kwak TI-RADS, ATA guidelines and KTA/KSThR guidelines in combination with SWE in the diagnosis of thyroid nodules.
    Zhang WB; Xu W; Fu WJ; He BL; Liu H; Deng WF
    Clin Hemorheol Microcirc; 2021; 78(2):163-174. PubMed ID: 33579829
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. FOXM1D potentiates PKM2-mediated tumor glycolysis and angiogenesis.
    Zhang W; Zhang X; Huang S; Chen J; Ding P; Wang Q; Li L; Lv X; Li L; Zhang P; Zhou D; Wen W; Wang Y; Lei QY; Wu J; Hu W
    Mol Oncol; 2021 May; 15(5):1466-1485. PubMed ID: 33314660
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CELF6 modulates triple-negative breast cancer progression by regulating the stability of fbp1 mRNA.
    Yang X; Zhao L; Pei J; Wang Z; Zhang J; Wang B
    Breast Cancer Res Treat; 2020 Aug; 183(1):71-82. PubMed ID: 32601971
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. cancer-associated mutations in human pyruvate kinase M2 impair enzyme activity.
    Liu VM; Howell AJ; Hosios AM; Li Z; Israelsen WJ; Vander Heiden MG
    FEBS Lett; 2020 Feb; 594(4):646-664. PubMed ID: 31642061
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Glycolytic reprogramming in cancer cells: PKM2 dimer predominance induced by pulsatile PFK-1 activity.
    Shi X; You L; Luo RY
    Phys Biol; 2019 Sep; 16(6):066007. PubMed ID: 31469100
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Functional cross-talk between allosteric effects of activating and inhibiting ligands underlies PKM2 regulation.
    Macpherson JA; Theisen A; Masino L; Fets L; Driscoll PC; Encheva V; Snijders AP; Martin SR; Kleinjung J; Barran PE; Fraternali F; Anastasiou D
    Elife; 2019 Jul; 8():. PubMed ID: 31264961
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. RNA sequencing of Xp11 translocation-associated cancers reveals novel gene fusions and distinctive clinicopathologic correlations.
    Wang XT; Xia QY; Ye SB; Wang X; Li R; Fang R; Shi SS; Zhang RS; Tan X; Chen JY; Sun K; Teng XD; Ma HH; Lu ZF; Zhou XJ; Rao Q
    Mod Pathol; 2018 Sep; 31(9):1346-1360. PubMed ID: 29713041
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. An engineered photoswitchable mammalian pyruvate kinase.
    Gehrig S; Macpherson JA; Driscoll PC; Symon A; Martin SR; MacRae JI; Kleinjung J; Fraternali F; Anastasiou D
    FEBS J; 2017 Sep; 284(18):2955-2980. PubMed ID: 28715126
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Structural insight into mechanisms for dynamic regulation of PKM2.
    Wang P; Sun C; Zhu T; Xu Y
    Protein Cell; 2015 Apr; 6(4):275-287. PubMed ID: 25645022
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prototype imaging protocols for monitoring the efficacy of iodine-131 ablation in differentiated thyroid cancer.
    Kobayashi M; Wakabayashi H; Kojima H; Konishi T; Okuda K; Yoneyama H; Kayano D; Tobisaka M; Tsushima H; Onoguchi M; Kawai K; Kinuya S
    Hell J Nucl Med; 2013; 16(3):175-80. PubMed ID: 24137580
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mitogenic and oncogenic stimulation of K433 acetylation promotes PKM2 protein kinase activity and nuclear localization.
    Lv L; Xu YP; Zhao D; Li FL; Wang W; Sasaki N; Jiang Y; Zhou X; Li TT; Guan KL; Lei QY; Xiong Y
    Mol Cell; 2013 Nov; 52(3):340-52. PubMed ID: 24120661
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV.
    de Micco C; Savchenko V; Giorgi R; Sebag F; Henry JF
    Br J Cancer; 2008 Feb; 98(4):818-23. PubMed ID: 18212751
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Iterative reconstruction: an improvement of technetium-99m MIBI SPET for the detection of parathyroid adenomas?
    Moka D; Eschner W; Voth E; Dietlein M; Larena-Avellaneda A; Schicha H
    Eur J Nucl Med; 2000 May; 27(5):485-9. PubMed ID: 10853801
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19.
    Mantovani LT; Miotti S; Ménard S; Canevari S; Raspagliesi F; Bottini C; Bottero F; Colnaghi MI
    Eur J Cancer; 1994; 30A(3):363-9. PubMed ID: 8204360
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.